Chemokinostatin-8

General Information


DRACP ID  DRACP02514

Peptide Name   Chemokinostatin-8

Sequence  DGRELCLDPKENWVQRVVEKFLK

Sequence Length  23

UniProt ID  P10145 

PubChem CID  Not available

Origin  Homo sapiens (CXCL8/IL-8)

Type  Native peptide

Classification

  

Active ACP Cancer targeted peptides Antiangiogenic



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  CXCR

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  DRACP02514

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C125H201N35O36S

Absent amino acids  AHIMSTY

Common amino acids  EKLV

Mass  319484

Pl  6.5

Basic residues  5

Acidic residues  5

Hydrophobic residues  8

Net charge  0

Boman Index  -6213

Hydrophobicity  -81.74

Aliphatic Index  88.7

Half Life 
  Mammalian: 1.1 hour
  Yeast: 3 min
  E.coli: >10 hour

Extinction Coefficient cystines  5500

Absorbance 280nm  250

Polar residues  3

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 18307172

Title  Novel anti-angiogenic peptides derived from ELR-containing CXC chemokines

Doi 10.1002/jcb.21712

Year  2008

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.